The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

The administration also told Vaxart Inc. to halt its research on an oral Covid vaccine, Bloomberg reports. In related news, the policy to cull poultry caught in H5N1 bird flu outbreaks will not be ...

A case of measles has been confirmed in Kentucky shortly after the first death to the illness in the U.S. since 2015.

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...